A4 Wealth Advisors LLC Buys New Stake in Sila Realty Trust, Inc. $SILA

A4 Wealth Advisors LLC bought a new stake in shares of Sila Realty Trust, Inc. (NYSE:SILA) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 27,934 shares of the company’s stock, valued at approximately $701,000. A4 Wealth Advisors LLC owned approximately 0.05% of Sila Realty Trust at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the business. Geode Capital Management LLC raised its stake in shares of Sila Realty Trust by 105.8% during the second quarter. Geode Capital Management LLC now owns 1,448,549 shares of the company’s stock valued at $34,290,000 after purchasing an additional 744,577 shares in the last quarter. Millennium Management LLC increased its stake in Sila Realty Trust by 114.4% during the 1st quarter. Millennium Management LLC now owns 607,111 shares of the company’s stock valued at $16,216,000 after buying an additional 323,917 shares during the period. Allianz Asset Management GmbH bought a new stake in shares of Sila Realty Trust during the 2nd quarter worth about $7,662,000. Jane Street Group LLC lifted its stake in shares of Sila Realty Trust by 25,141.8% in the 1st quarter. Jane Street Group LLC now owns 224,904 shares of the company’s stock worth $6,007,000 after acquiring an additional 224,013 shares during the period. Finally, Frontier Capital Management Co. LLC boosted its holdings in shares of Sila Realty Trust by 8.7% in the second quarter. Frontier Capital Management Co. LLC now owns 2,531,194 shares of the company’s stock valued at $59,913,000 after acquiring an additional 202,976 shares in the last quarter.

Analyst Upgrades and Downgrades

SILA has been the topic of several recent analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Sila Realty Trust in a report on Monday, December 29th. Wells Fargo & Company dropped their price objective on Sila Realty Trust from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 25th. Finally, Wolfe Research assumed coverage on Sila Realty Trust in a research note on Monday, October 20th. They set a “peer perform” rating and a $27.00 target price for the company. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $26.67.

Sila Realty Trust Trading Down 0.2%

Shares of NYSE SILA opened at $24.35 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.50. Sila Realty Trust, Inc. has a 12 month low of $21.94 and a 12 month high of $27.50. The company has a market cap of $1.34 billion, a price-to-earnings ratio of 35.29 and a beta of -0.02. The business has a fifty day simple moving average of $23.48 and a 200-day simple moving average of $24.17.

Sila Realty Trust (NYSE:SILA) last released its earnings results on Tuesday, November 4th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.54 by ($0.33). The firm had revenue of $49.85 million during the quarter, compared to analysts’ expectations of $49.73 million. Sila Realty Trust had a return on equity of 2.80% and a net margin of 19.86%. Sell-side analysts predict that Sila Realty Trust, Inc. will post 2.23 EPS for the current year.

Sila Realty Trust Profile

Sila Realty Trust, Inc, headquartered in Tampa, Florida, is a net lease real estate investment trust with a strategic focus on investing in the large, growing, and resilient healthcare sector. The Company invests in high quality healthcare facilities along the continuum of care, which, we believe, generate predictable, durable, and growing income streams. Our portfolio comprises high quality tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients.